FIBROBIOLOGICS INC (FBLG) Stock Income Statement
USA - NASDAQ:FBLG - US31573L1052 - Common Stock
0.3933 USD
0 (-0.91%)
0.4 USD
+0.01 (+1.7%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 16.09M | 13.74M | 8.89M | 4.47M | 1.58M | |||
| Research and Development | 6.39M | 4.50M | 2.37M | 1.15M | 521.00K | |||
| Selling, General, and Administrative Expenses | 9.70M | 9.23M | 6.52M | 3.32M | 1.06M | |||
| Operating Income | -16.09M | -13.74M | -8.89M | -4.47M | -1.58M | |||
| Interest Income/Expense | 1.01M | -414.00K | -147.00K | -654.00K | -4.00K | |||
| Other Income/Expense | 641.00K | 1.78M | -7.45M | N/A | N/A | |||
| Non Recurring Items | N/A | 1.21M | N/A | N/A | N/A | |||
| Income Before Taxes | -13.22M | -11.16M | -16.48M | -5.12M | -1.58M | |||
| Net Income | -13.22M | -11.16M | -19.06M | -5.12M | -1.58M | |||
| EBITDA | -15.89M | -13.58M | -8.84M | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.36 | -0.34 | -0.68 | -0.16 | -0.05 | |||
| Non GAAP EPS | -0.36 | N/A | N/A | N/A | N/A | |||
| Statistics | ||||||||
All data in USD